​​FDA to allow 23andMe to report more BRCA variants; Janssen secures deal with AI-drug discovery outfit”

23andMe received FDA clearance to report an additional 41 variants in the BRCA1 and BRCA2 genes, which are associated with a higher risk of breast, ovarian, prostate and pancreatic cancer.

Many of the additional variants are more likely to occur in Black and Hispanic populations. It’s…
Click here to view original post